Fabian Martin Troschel

18PUBLICATIONS
34CO-AUTHORS
Molecular targetsRadiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples youth and family
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 17, 2026
Ro 08-2750 increases radiation-induced cytotoxicity in DLBCL by dysregulating the DNA damage response.

|Nov 09, 2024
Efficacy and Low Toxicity of Normo-Fractionated Re-Irradiation with Combined Chemotherapy for Recurrent Glioblastoma-An Analysis of Treatment Response and Failure.

Niklas Benedikt Pepper, Nicholas Grischa Prange, Fabian Martin Troschel

|Oct 25, 2024
Risk factors for treatment-related sensorineural hearing loss and hearing aid use in medulloblastoma patients: an observational cohort study.

Fabian M Troschel, David Rene Steike, Julian Roers

|Aug 29, 2024
Antioxidants Hydroxytyrosol and Thioredoxin-Mimetic Peptide CB3 Protect Irradiated Normal Tissue Cells.

Katrin Borrmann, Fabian Martin Troschel, Kathrin Annemarie Brücksken

|Mar 28, 2024
Sarcopenia is associated with chemoradiotherapy discontinuation and reduced progression-free survival in glioblastoma patients.

Fabian M Troschel, Benjamin O Troschel, Maren Kloss

|May 26, 2022
Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiation.

Isabel Falke, Fabian M Troschel, Heike Palenta

Pageof 3

Frequent Collaborators

4 joint publications

Burkhard Greve

3 joint publications

Amelie S Völk-Troschel

3 joint publications

Martin Götte

2 joint publications

Michael Oertel